Epstein Secrets

From: Harry Fisch Sent: Wednesday, April 25, 2018 8:10 PM To: Jeffrey Epstein Subject: FDA advisory committee votes to recommend update to celecoxib safety labeling Family Practice News https://www.mdedge.com/familypractice

Wednesday, April 25, 2018 8:10 PM To: Jeffrey Epstein Subject: FDA advisory committee votes to recomm

h Sent: Wednesday, April 25, 2018 8:10 PM To: Jeffrey Epstein Subject: FDA advisory committee votes t

, naproxen, and ibuprofen and their cardiovascu=ar outcomes. The PRECISION trial was undertaken after another selective COX=2 inhibitor, rofecoxib (Vioxx), was withdrawn from the market because of as=ociated cardiovascular events. It compared the three drugs among more than 2=,000 patients with painfu

From: Sultan Bin Sulayern Sent: 7/24/2015 8:37:24 PM To: Jeffrey Epstein [[email protected]] Subject: Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today Importance: — High Have you heard of this co

Sulayern Sent: 7/24/2015 8:37:24 PM To: Jeffrey Epstein [[email protected]] Subject: Fwd: FDA Approve

Recent Posts ° Popular Posts I believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today. Email me, follow me on Twitter, circle me onGoogle Plus, or subscribe to my Facebook page.

From: Deepak Chopra Sent: Monday, August 1, 2016 12:29 PM To: Jeff Epstein Subject: Fw: Draft OpEd piece on FDA sharing confidentially Writing this up for WSJ now 2013 Costa Del Mar Road Carlsbad, CA 92009 The Chopra F

Sent: Monday, August 1, 2016 12:29 PM To: Jeff Epstein Subject: Fw: Draft OpEd piece on FDA sharing co

ted, and if you believe that more voices add credibility, they can be invited? Eric Topol may have an interest since he was instrumental in exposing Vioxx as a major cardiovascular risk agent, and having it withdrawn by the FDA. Looking forward to your thoughts, comments, and suggestions. Love, Joe

From: jeffrey E. [[email protected]] Sent: 7/24/2015 8:47:39 PM To: Sultan Bin Sulayern Subject: Re: FDA Approved a Potent and Pricey Cholesterol lowering drug t

Recent Posts ° Popular Posts I believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today. Email me, follow me on Twitter, circle me onGoogle Plus, or subscribe to my Facebook page.